Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Total Non-Current Liabilities (2018 - 2025)

Historic Total Non-Current Liabilities for BioNexus Gene Lab (BGLC) over the last 8 years, with Q3 2025 value amounting to $126943.0.

  • BioNexus Gene Lab's Total Non-Current Liabilities fell 3388.83% to $126943.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $126943.0, marking a year-over-year decrease of 3388.83%. This contributed to the annual value of $159741.0 for FY2024, which is 4388.75% up from last year.
  • According to the latest figures from Q3 2025, BioNexus Gene Lab's Total Non-Current Liabilities is $126943.0, which was down 3388.83% from $141347.0 recorded in Q2 2025.
  • Over the past 5 years, BioNexus Gene Lab's Total Non-Current Liabilities peaked at $194615.0 during Q2 2024, and registered a low of $39659.0 during Q3 2022.
  • Over the past 5 years, BioNexus Gene Lab's median Total Non-Current Liabilities value was $71072.0 (recorded in 2022), while the average stood at $99753.5.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 23724.25% in 2023, then tumbled by 3388.83% in 2025.
  • Over the past 5 years, BioNexus Gene Lab's Total Non-Current Liabilities (Quarter) stood at $65856.0 in 2021, then increased by 7.92% to $71072.0 in 2022, then soared by 56.2% to $111018.0 in 2023, then surged by 43.89% to $159741.0 in 2024, then decreased by 20.53% to $126943.0 in 2025.
  • Its Total Non-Current Liabilities was $126943.0 in Q3 2025, compared to $141347.0 in Q2 2025 and $147940.0 in Q1 2025.